From avoiding digital health failure to BIO 2015: 5 must-read stories from MedCity News this week
Check out a recap of the BIO and Health Innovation conferences from MedHeads and other top stories from this week.
#BIO2015: What life sciences sectors are ripe for M&A?
Life sciences M&A remains bullish - 2015 will likely outpace 2014 in terms of deals. But which sectors are most lucrative? CNS, pain and women's health, a new report from Campbell Alliance finds.
presented by
These Are the Top-Rated Autism Therapy Centers in Texas
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
New institute refines hackathon concepts for business
The Hacking Medicine Institute is rejiggering hackathon concepts so they're applicable to the business of healthcare. But in some ways, it's the anti-hackathon. "At MIT, we love technology," said Ayesha Khalid, co-founder of the Institute. "But I don't think the solution here is more technology."
Eric Topol: Frustrated that doctors are slow to adopt pharmacogenomics
"We basically have a medical community that doesn't embrace the use of genomics," Dr. Eric Topol said. "Often times these days, it's the patients that are clamoring."
Topol: Clinical trials offer exciting examples of convergence of digital health and drug development
Dr. Eric Topol said, "When I wrote 'Creative Destruction of Medicine' four years ago there was zero convergence...Now there are so many examples."
#BIO2015: BIO’s now “Biotechnology Innovation Organization” (Groan)
Can we think of a less innovative word these days than "innovative?" BIO doesn't seem to care, given its hackneyed new name change.
presented by
Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
#BIO2015: Nanomedicine… the next big thing?
Nanomedicine is emerging in the life sciences as a potent way to enhance drug performance - but the applications don't stop there, according to a panel of proponents speaking at BIO.
#BIO2015: The digital disruptors are making their mark in healthcare
Digital health has the potential to make healthcare delivery more efficient but it will be an occasionally uncomfortable transformation with plenty of push back.
#BIO2015: Improving basic science research with a translational model
A new Battelle report examines new trends in translational science among academia-industry collaboration, and the impact it has on basic science research.
#BIO2015: Open-source biopharma R&D improves late-stage success
Collaboration, even with competitors, helps usher a drug into successful development, a new report from Deloitte released at this week's BIO convention says.
presented by
Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software
Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.
#BIO2015: Are venture capitalists too focused on the science?
Vertex Pharmaceuticals founder Joshua Boger says that venture capitalists have too much of a say in how to shape a startup - when really, it should be left up to a solid team of scientists.